COVID-19: Get the latest updates or take a self-assessment.
Adults who are admitted to an inpatient setting with a primary diagnosis of schizophrenia are offered behavioural and pharmacological interventions to alleviate nicotine-withdrawal symptoms and to help them reduce or stop smoking tobacco.
Cigarette smoking rates among people with schizophrenia are much higher than in the general population. High tobacco use contributes to the main causes of morbidity and mortality in people with schizophrenia. Tobacco use may also interfere with the effectiveness and mechanisms of action of certain antipsychotic medications. People with schizophrenia should be offered interventions to stop or reduce smoking that are aligned with their readiness for change.
You should be offered services or programs that may help you to stop smoking or smoke less. Quitting or cutting down on smoking can help improve your physical and mental health.
Offer smoking-cessation behavioural interventions, counselling, or medications to people with schizophrenia who smoke tobacco to alleviate their nicotine-withdrawal symptoms and help them reduce or stop smoking.
Ensure that there are smoking-cessation behavioural interventions and medications available in hospitals for people with schizophrenia who smoke.
Percentage of adults admitted to an inpatient setting with a primary diagnosis of schizophrenia who are current smokers who receive behavioural and/or pharmacological interventions to alleviate nicotine-withdrawal symptoms and help them reduce or stop smoking
Denominator: total number of adults admitted to an inpatient setting with a primary diagnosis of schizophrenia who are current smokers or who are quitting smoking but experiencing nicotine-withdrawal symptoms
Numerator: number of people in the denominator who receive behavioural and/or pharmacological interventions to alleviate nicotine-withdrawal symptoms and help them reduce or stop smoking• Data source: local data collection
Data source: local data collection
Availability of programs for adults admitted to an inpatient setting with a primary diagnosis of schizophrenia that promote healthy eating or physical activity
These interventions may be offered in hospital and include:
Motivational interviewing
Behavioural support
Nicotine replacement therapy products (e.g., transdermal patches,gum, inhalation cartridges, sublingual tablets, or spray) such as varenicline or bupropion
Adequately dosed pharmacotherapy
Patients, families and the public are central to improving health quality.
Are you passionate about quality health care for all Ontarians? Stay in-the-know about our newest programs, reports and news.